Structural Formula (Ibuprofen Lysine Injection 1)
Ibuprofen Lysine Solution
Product Images NDC 39822-1030
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ibuprofen Lysine (NDC 39822-1030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xgen Pharmaceuticals Djb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ibul-vl-03 (Ibuprofen Lysine Injection 2)
XGen® is a pharmaceutical product or brand name that may belong to a company called DJB. No further details are available.*
Ibuprofen Lysine Injection 3
Ibuprofen Lysine Injection 4
Ibuprofen Lysine Injection 5
This is a description of Ibuprofen Lysine 20 mg/2 mL injection, which is only for intravenous use. Each milliliter contains 10 mg of ibuprofen lysine in water for injection. The injection should be diluted to an appropriate volume with dextrose or saline. Storage should be done at 20-25°C (68-77°F) with excursions permitted at 15-30°C (59-86°F). The vials should be stored in a carton when not in use. However, the given text at the end seems to be not readable and hence description about the same is not-available.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
